Radcliffe Capital Management
CDIOW icon

Radcliffe Capital Management’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

Radcliffe Capital Management’s Portfolio CDIOW Stock Details CDIOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-50,000
Closed -$53K – 697
2022
Q4 		$53K Hold
50,000
– – ﹤0.01% 871
2022
Q3 		$502K Hold
50,000
– – 0.01% 1070
2022
Q2 		$497K Hold
50,000
– – 0.01% 1126
2022
Q1 		$495K Buy
+50,000
New +$11.9K 0.01% 1131

Other funds holding CDIOW

Boothbay Fund Management
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
EHP Funds Inc
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Saba Capital Management
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
Clear Street
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
Context Capital Management
Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return
Rivernorth Capital Management
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Radcliffe Capital Management's CDIOW Position: Q1 2023 in Review

Radcliffe Capital Management sold out of Cardio Diagnostics Holdings Inc Warrant (CDIOW) in Q1 2023, closing a stake of 50,000 shares — an estimated $53K sold.

Radcliffe Capital Management first reported a position in CDIOW in Q1 2022 and held it in 4 quarters. The position peaked at $502K in Q3 2022. 16 funds tracked by Wall St. Rank hold CDIOW as of Q1 2023.

  • Radcliffe Capital Management reported no remaining Cardio Diagnostics Holdings Inc Warrant position as of Q1 2023 after selling out during the quarter.
  • Radcliffe Capital Management sold 50,000 Cardio Diagnostics Holdings Inc Warrant shares in Q1 2023, an estimated $53K.
  • Radcliffe Capital Management first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q1 2022 and held it in 4 quarters.
  • Radcliffe Capital Management's Cardio Diagnostics Holdings Inc Warrant position peaked at $502K in Q3 2022.
  • 16 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q1 2023.

Based on Radcliffe Capital Management's 13F filing for Q1 2023, filed 15 May 2023.